Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by skyhigh123on Mar 21, 2018 2:25pm

226 Views

Post# 27755311

IMPORTANT PLEASE READ

MEETING POSTPONED: March 22, 2018: Pediatric Advisory Committee and Endocrinologic and Metabolic Drugs Advisory Committee Meeting Announcement

Due to the inclement weather, the PAC Meetings on March 22- 23, 2018 are postponed until further notice.

Date	Time	Location
March 22, 2018	8:00 a.m.- 11 a.m. (Closed Session) 12:00 p.m. - 6:00 p.m. (Open Session)	FDA White Oak Campus 10903 New Hampshire Avenue Building 31 Conference Center The Great Room (Rm. 1503) Silver Spring, MD 20993